These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37466368)

  • 21. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
    Blom AM; Kask L; Dahlbäck B
    Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
    Seya T; Okada M; Matsumoto M; Hong KS; Kinoshita T; Atkinson JP
    Mol Immunol; 1991 Oct; 28(10):1137-47. PubMed ID: 1833639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME; Nussenzweig V
    J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
    J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement alternative pathway activation and control on membranes of human lymphoid B cell lines.
    Caudwell V; Porteu F; Calender A; Pangburn MK; Halbwachs-Mecarelli L
    Eur J Immunol; 1990 Dec; 20(12):2643-50. PubMed ID: 1702720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z; Müller-Eberhard HJ
    J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement.
    Pangburn MK; Pangburn KL; Koistinen V; Meri S; Sharma AK
    J Immunol; 2000 May; 164(9):4742-51. PubMed ID: 10779780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of high-affinity C5 convertases of the alternative pathway of complement.
    Rawal N; Pangburn M
    J Immunol; 2001 Feb; 166(4):2635-42. PubMed ID: 11160326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I.
    Cunnion KM; Hair PS; Buescher ES
    Infect Immun; 2004 May; 72(5):2858-63. PubMed ID: 15102797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kallikrein Cleaves C3 and Activates Complement.
    Irmscher S; Döring N; Halder LD; Jo EAH; Kopka I; Dunker C; Jacobsen ID; Luo S; Slevogt H; Lorkowski S; Beyersdorf N; Zipfel PF; Skerka C
    J Innate Immun; 2018; 10(2):94-105. PubMed ID: 29237166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae.
    Jimenez-Lucho VE; Joiner KA; Foulds J; Frank MM; Leive L
    J Immunol; 1987 Aug; 139(4):1253-9. PubMed ID: 2440949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
    Nilsson-Ekdahl K; Nilsson B
    Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact.
    Pryzdial EL; Isenman DE
    J Biol Chem; 1987 Feb; 262(4):1519-25. PubMed ID: 3643213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
    Joiner K; Sher A; Gaither T; Hammer C
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein.
    McRae JL; Duthy TG; Griggs KM; Ormsby RJ; Cowan PJ; Cromer BA; McKinstry WJ; Parker MW; Murphy BF; Gordon DL
    J Immunol; 2005 May; 174(10):6250-6. PubMed ID: 15879123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The alternative pathway of complement.
    Pangburn MK; Müller-Eberhard HJ
    Springer Semin Immunopathol; 1984; 7(2-3):163-92. PubMed ID: 6238433
    [No Abstract]   [Full Text] [Related]  

  • 37. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
    Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The structure of complement C3b provides insights into complement activation and regulation.
    Abdul Ajees A; Gunasekaran K; Volanakis JE; Narayana SV; Kotwal GJ; Murthy HM
    Nature; 2006 Nov; 444(7116):221-5. PubMed ID: 17051152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b.
    Johnson JB; Borisevich V; Rockx B; Parks GD
    J Virol; 2015 Jan; 89(2):989-98. PubMed ID: 25355897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
    Meri S; Pangburn MK
    Eur J Immunol; 1990 Dec; 20(12):2555-61. PubMed ID: 2148521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.